10/27/2025
There is strong evidence in general behavioural weight-loss literature that more frequent self-weighing is associated with better outcomes in a large cohort of smart scale users, daily self-weighing was associated with greater weight loss compared with less frequent weighing in patients NOT on GLP-1!!
⚠️ What we don’t have yet
No study (at least in the publicly available literature) has broken down self-weighing frequency specifically in a GLP-1 RA treated population (i.e., comparing daily vs weekly weighing in people on GLP-1s)
We also lack evidence on how fluctuations under GLP-1 (which may have different dynamics—e.g., changes in body composition, fluid shifts, metabolic adaptations) relate to weighing frequency and mindset
With GLP-1 therapy, weight loss may be rapid (especially early on) and influenced by fluid changes, shifts in body composition (less fat, more lean preservation), and medication‐effects (e.g., satiety, metabolic shift). So day-to-day fluctuations may be more pronounced.
